Hear how AI is transforming patient identification and engagement in Canada, and what that means for more timely, targeted rare disease support.
Unpack how AI is accelerating mis- and disinformation in rare disease, and what industry can do to build trust and improve the quality of information patients and HCPs receive.
Hear from leaders on how rare disease support must evolve to become more useful, connected and responsive to real patient and HCP needs in the age of ai.
This event is for professionals employed by pharma, biotech, medtech, healthcare providers, and advocacy who are working to improve outcomes in rare disease in Canada.
Enjoy stunning views across downtown Toronto from the ChangeMakers Health office.
